L-carnosine as an adjuvant to fluvoxamine in treatment of obsessive compulsive disorder: A randomized double-blind study (original) (raw)
Randomized, Double-Blind, Placebo-Controlled Trial of N-Acetylcysteine Augmentation for Treatment-Resistant Obsessive-Compulsive Disorder
Daniel Las Casas
The Journal of clinical psychiatry, 2017
View PDFchevron_right
Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder
John Krystal
NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics, 2006
View PDFchevron_right
Serotonin reuptake blockers: Is there preclinical evidence for their efficacy in obsessive-compulsive disorder?
Jan Mos
Human Psychopharmacology: Clinical and Experimental, 1991
View PDFchevron_right
Efficacy of N-Acetylcysteine Augmentation on Obsessive Compulsive Disorder: A Multicenter Randomized Double Blind Placebo Controlled Clinical Trial
ali firoozabadi
Iranian journal of psychiatry, 2017
View PDFchevron_right
Comparison of Saffron and Fluvoxamine in the Treatment of Mild to Moderate Obsessive-Compulsive Disorder: A Double Blind Randomized Clinical Trial
Shahin Akhondzadeh
Iranian journal of psychiatry, 2017
View PDFchevron_right
Obsessive compulsive disorder and the glutamatergic system
Catherine Nyuthe
Current Opinion in Psychiatry, 2014
View PDFchevron_right
Investigational and Experimental Drugs to Treat Obsessive-Compulsive Disorder
Chiara Cecchelli
Journal of Experimental Pharmacology, 2021
View PDFchevron_right
Efficacy of combination of fluoxetine and cognitive behavioral therapy and fluoxetine alone for the treatment of obsessive compulsive disorder
Noor Giasuddin
Pakistan journal of pharmaceutical sciences, 2013
View PDFchevron_right
Adjunctive glycine in the treatment of obsessive-compulsive disorder in adults
Melissa Benedict, Laura Panek
Journal of Psychiatric Research, 2009
View PDFchevron_right
Randomized Controlled Crossover Trial of Ketamine in Obsessive-Compulsive Disorder: Proof-of-Concept
Donna Vermes
Neuropsychopharmacology, 2013
View PDFchevron_right
Fluvoxamine and sulpiride in comorbid obsessive-compulsive disorder and gilles de la tourette syndrome
Mark George
Human Psychopharmacology: Clinical and Experimental, 1993
View PDFchevron_right
In vivo effects of ketamine on glutamate-glutamine and gamma-aminobutyric acid in obsessive-compulsive disorder: Proof of concept
Dikoma C Shungu
Psychiatry Research: Neuroimaging, 2015
View PDFchevron_right
Glutamatergic medications as adjunctive therapy for moderate to severe obsessive-compulsive disorder in adults: a systematic review and meta-analysis
Shayan Kashefinejad
BMC Pharmacology and Toxicology
View PDFchevron_right
N-Acetylcysteine Add-On Treatment in Refractory Obsessive-Compulsive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial
Mohammad Haghighi
2012
View PDFchevron_right
On the Pharmacotherapy of Obsessive—Compulsive Disorder: Is a Consensus Possible?
François Borgeat
The Canadian Journal of Psychiatry, 2000
View PDFchevron_right
A pilot study of biological predictors of treatment outcome in obsessive-compulsive disorder
Donald Klein
Biological Psychiatry, 1993
View PDFchevron_right
N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder
John Krystal, Ben Kelmendi
Psychopharmacology, 2006
View PDFchevron_right
Exposure therapy, fluvoxamine, or combination treatment in obsessive-compulsive disorder: One-year followup
Isaac Marks
Psychiatry Research, 1993
View PDFchevron_right
Plasma fluvoxamine levels and OCD symptoms/response in adult patients
Gabriele Massimetti
Human Psychopharmacology: Clinical and Experimental, 2012
View PDFchevron_right
Anterior cingulate glutamate–glutamine levels predict symptom severity in women with obsessive–compulsive disorder
Christos Pantelis
Australian and New Zealand Journal of Psychiatry, 2008
View PDFchevron_right
Long–term course and outcome of obsessive–compulsive patientsafter cognitive–behavioral therapy in combination with eitherfluvoxamine or placebo
Michael Rufer
European Archives of Psychiatry and Clinical Neuroscience, 2005
View PDFchevron_right
Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study
Stefano Erzegovesi
European Neuropsychopharmacology, 2005
View PDFchevron_right
Effectiveness of fluoxetine on various subtypes of obsessive-compulsive disorder
Alireza Farnam
Archives of Iranian medicine, 2008
View PDFchevron_right
Double-blind comparison of fluoxetine versus clomipramine in the treatment of obsessive compulsive disorder
María Hernández
European Neuropsychopharmacology, 1996
View PDFchevron_right
Pharmacotherapy for obsessive-compulsive disorder
Michael Jenike, Darin Dougherty
Advances in Psychiatric Treatment, 2011
View PDFchevron_right
A Double-Blind, Randomized, Controlled Trial of Fluoxetine Plus Quetiapine or Clomipramine Versus Fluoxetine Plus Placebo for Obsessive-Compulsive Disorder
Lorrin Koran
Journal of Clinical Psychopharmacology, 2011
View PDFchevron_right
Psychopharmacological treatment of Obsessive-Compulsive Disorder (OCD)
Dorian Lamis
Current neuropharmacology, 2018
View PDFchevron_right
Current trends in drug treatment of obsessive–compulsive disorder
Dan Stein
Neuropsychiatric Disease and Treatment, 2010
View PDFchevron_right
N-Acetylcysteine Add-On Treatment in Refractory Obsessive-Compulsive Disorder
Hamidreza Roohafza
Journal of Clinical Psychopharmacology, 2012
View PDFchevron_right
Emerging drugs to treat obsessive–compulsive disorder
Stefano Pallanti
Expert Opinion on Emerging Drugs, 2013
View PDFchevron_right
Role of Glutamatergic System in Obsessive-Compulsive Disorder with Possible Therapeutic Implications
Jiri Horacek
Pharmacopsychiatry, 2017
View PDFchevron_right